DI NATALE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.005
AS - Asia 1.914
EU - Europa 1.367
SA - Sud America 226
AF - Africa 30
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.545
Nazione #
US - Stati Uniti d'America 1.942
SG - Singapore 866
RU - Federazione Russa 501
VN - Vietnam 365
CN - Cina 326
IT - Italia 191
BR - Brasile 179
UA - Ucraina 179
HK - Hong Kong 159
DE - Germania 123
FR - Francia 99
FI - Finlandia 66
IE - Irlanda 55
SE - Svezia 51
JP - Giappone 49
CA - Canada 38
GB - Regno Unito 32
IN - India 29
NL - Olanda 27
AR - Argentina 15
MX - Messico 14
TR - Turchia 14
ID - Indonesia 13
PH - Filippine 12
PL - Polonia 12
IQ - Iraq 11
BD - Bangladesh 10
TH - Thailandia 10
VE - Venezuela 8
ZA - Sudafrica 8
ES - Italia 7
BE - Belgio 6
CI - Costa d'Avorio 6
EC - Ecuador 6
KR - Corea 6
SA - Arabia Saudita 6
AT - Austria 5
CL - Cile 5
EG - Egitto 5
LT - Lituania 5
PK - Pakistan 5
PY - Paraguay 5
CO - Colombia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
KE - Kenya 3
MY - Malesia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
IL - Israele 2
JO - Giordania 2
LB - Libano 2
MN - Mongolia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CY - Cipro 1
GA - Gabon 1
GM - Gambi 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
MK - Macedonia 1
MM - Myanmar 1
MR - Mauritania 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.545
Città #
Singapore 394
Chandler 331
San Jose 203
Jacksonville 169
Beijing 154
Hong Kong 153
Santa Clara 135
Moscow 125
Ho Chi Minh City 116
Ashburn 111
Millbury 77
Hanoi 73
Princeton 61
Lauterbourg 56
Naples 49
Tokyo 44
The Dalles 38
Nanjing 37
Woodbridge 36
Lusciano 35
Los Angeles 32
Ottawa 28
Wilmington 25
Kronberg 24
Buffalo 23
Ann Arbor 22
Napoli 20
Redondo Beach 20
Amsterdam 16
Boston 16
Houston 15
New York 15
São Paulo 15
Haiphong 13
Dallas 12
Norwalk 12
Munich 11
Falkenstein 10
Hebei 10
Nanchang 10
Pune 10
Warsaw 10
Changsha 9
Da Nang 9
Dearborn 9
Frankfurt am Main 9
Mexico City 9
Nuremberg 9
Atlanta 8
Biên Hòa 8
Boardman 8
Düsseldorf 8
Tianjin 8
Can Tho 7
Denver 7
Seattle 7
Thái Bình 7
Belo Horizonte 6
Falls Church 6
Johannesburg 6
Orem 6
Rome 6
Washington 6
Augusta 5
Brooklyn 5
Casoria 5
Chennai 5
Hefei 5
Helsinki 5
Hải Dương 5
Istanbul 5
Milan 5
Rio de Janeiro 5
San Francisco 5
Albacete 4
Ankara 4
Bangkok 4
Chicago 4
Council Bluffs 4
Ha Long 4
London 4
Phoenix 4
Poplar 4
Quận Ba 4
Resistencia 4
Riyadh 4
Shenyang 4
St Louis 4
Waanrode 4
Baghdad 3
Brasília 3
Bridgetown 3
Cairo 3
Curitiba 3
Des Moines 3
Jakarta 3
Jiaxing 3
Kunming 3
Manila 3
Montevideo 3
Totale 3.072
Nome #
Activation of stress kinases in the brain of mucopolysaccharidosis IIIB mice 195
The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure 150
Echistatin inhibits adhesion of murine melanoma cells to extracellular matrix components. 139
Differences in methylation patterns in the methylation boundary region of IDS gene in Hunter syndrome patients: implications for CpG hot spot mutations 134
A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency 133
Detection of four novel mutations in the iduronate-2-sulfatase gene 132
Gene symbol: SGSH. Disease: Sanfilippo type A syndrome, mucopolysaccharidosis IIIA. 128
Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients 125
Echistatin inhibits pp125FAK autophosphorylation, paxillin phosphorylation and pp125FAK-paxillin interaction in fibronectin-adherent melanoma cells. 119
Molecular markers for the follow-up of enzyme replacement therapy in mucopolysaccharidosis VI disease. 118
Analisi dei meccanismi d'interazione delle disintegrine con i recettori integrinici sulla superficie delle cellule B16-BL6 e delle piastrine 116
Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects Mucopolysaccharidosis type I phenotype in the mouse model. 116
Gene symbol: IDS. Disease: mucopolysaccharidosis type II (Hunter syndrome) 116
Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). 112
Interazione echistatina-integrine in cellule B16-BL6 adese alla fibronectina: organizzazione del citoscheletro ed eventi di fosforilazione 106
Effetto dell'echistatina sulla fosforilazione di pp125FAK in cellule adese alla fibronectina 106
Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C Syndrome). 102
L'echistatina induce il “detachment” delle cellule B16-BL6 adese alla matrice extracellulare 102
Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector 101
Mucopolysaccharidoses types I and IIIB: gene therapy by lentiviral vectors 98
Treatment of the mouse model of mucopolysaccharidosis type IIIB with lentiviral-NAGLU vector 97
Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with Mucopolysaccharidosis type I by liver-directed gene therapy 96
Large deletion involving exon 5 of the ARSB gene caused apparent homozygosity in a mucopolysaccharidosis type VI patient 96
Gene symbol: IDS. Disease: mucopolysaccharidosis type II (Hunter syndrome). 95
Trasferimento mediato da lentivirus del cDNA umano per l'enzima NAGLU in fibroblasti di pazienti con mucopolisaccaridosi IIIB 92
Gene therapy for mucopolysaccharidosis type I and type IIIB by lentiviral vectors 91
An adult Sanfilippo type A patient with homozygous mutation R206P in the sulfamidase gene 91
Lentiviral vectors-mediated gene therapy for mucopolysaccharidosis type IIIB 90
Expression studies of Sanfilippo A mutations 90
Characterization of five iduronate-2-sulfatase site-directed mutations 90
Molecular defects in the alfa-N-acetylglucosaminidase gene 89
Treatment of mucopolysaccharidosis type I by lentiviral vector transducing the human alfa-L-iduronidase gene 89
Identificazione e caratterizzazione di mutazioni sul gene per l'alfa-N-acetilglucosaminidasi 88
Heparin sulfamidase S66W allele: the first early prenatal diagnosis of Sanfilippo type A syndrome 86
Mucopolysaccharidoses: from gene defect to protein expression 86
Unfolded Protein Response is not activated in the mucopolysaccharidoses but protein disulfide isomerase 5 is deregulated 86
Two novel mutations of the arylsulfatase B gene in two Italian patients with the severe form of mucopolysaccharidosis VI 84
Identification of molecular alterations in Sanfilippo B patients 83
18th Workshop of European Study Group on Lysosomal Diseases (ESGLD) 83
Disintegrins as agents for dissecting integrin-mediated cell signaling 82
Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype. 82
Lentiviral vector-mediated gene therapy for Sanfilippo B syndrome (MPS IIIB) 81
Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2 79
Vettori lentivirali come strumenti per la terapia genica delle mucopolisaccaridosi I e IIIB 76
Mucopolysaccharidoses: from gene defect to protein expression 75
Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB. 74
Mucopolisaccaridosi IIIA: espressione in vitro di 15 difetti molecolari 73
L'echistatina inibisce l'adesione di cellule di melanoma murino B16-BL6 ai componenti della matrice extracellulare 72
Gene therapy of Sanfilippo type B syndrome using a lentiviral vector 71
Coexistence of mutations R315X and g.99367-102002del both involving the exon 5 of ARSB gene caused a misdiagnosis for a MPS VI patient. 71
Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB. 68
“Analisi delle mutazioni nel gene dell'iduronato-2-solfatasi in pazienti Hunter” 67
Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis. 64
Oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis of mucopolysaccharidosis IIIB 61
Molecular pathology of mucopolysaccaridosis IIIB 59
Fabry disease associated with G6PD definciency 59
Molecular pathology of the mucopolysaccaridoses 58
MPS VI disease: evaluation of molecular markers for the follow-up of enzyme replacement therapy 57
A novel splicing mutation in a MPS II (Hunter syndrome) patient. 54
Intracranial injections of lentiviral-NAGLU vector in MPS IIIB mice: effect of treatment on cytokines, neurotrophins and oxidative stress 52
In vivo gene transfer for mucopolysaccharidosis type I and type IIIB animal models 48
Totale 5.633
Categoria #
all - tutte 18.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 0 41 5
2021/2022324 4 0 0 1 1 7 0 9 63 22 62 155
2022/2023549 82 82 22 62 79 59 2 45 91 9 13 3
2023/2024253 17 46 17 10 20 40 4 33 2 0 44 20
2024/20251.300 79 74 5 7 44 136 160 73 116 120 396 90
2025/20262.315 242 190 220 203 431 76 268 179 309 173 24 0
Totale 5.633